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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the
control.
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages
because growth is still exponential.
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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(0) Executive summary – Dashboard
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Global EU+EFTA+UK trends and needs 
EU+EFTA+UK countries have definitely 
lost leadership in absolute number of 
cases worldwide. Currently, the USA, 
Russia and Brazil are clearly the 
leaders. USA has been the country with 
highest number of cases since March 
27, surpassing Italy at that time. Russia 
overtook Spain on May 13, which was 
the European leader that day. Brazil 
has overtaken the UK today, according 
to ECDC data.  
On the other hand, while European 
countries are significatively slowing 
down their growth, the USA, Russia 
and Brazil are still growing 
dramatically, without any symptom of 
slowdown. The epicenter of the epidemic has definitely shifted. It started in China, then jumped to Europe, 
and now it is clearly growing in the Americas. 
Today’s analysis and those of the following days are focused on discussing the role of test and tracing and 
mobility on the deconfinement process. They have been elaborated together with researchers from the 
Barcelona Supercomputing Center.  
Trends for specific countries 
Globally, EU+EFTA+UK countries are gradually moving to the level of 5,000 daily new cases. UK seems 
stabilizing at ρ7 = 0.8, thus plenty entering a decreasing stage. Sweden reports a low number of new cases 
today, which drags the ρ7 below 1. Both countries show a gradual decrease in EPG.  
The map in the left shows current A14. The map in the right shows current EPG.   
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Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is 
applied independently to each column, and distinguishes best (green) form worst (red) situations according 
to each of the variables. Last column (EPGEST) indicates EPG assessed with estimated real 14-day attack rate 
(see report from 22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST 
cannot be compared between them because scales are different, but can be independently used for 
estimating risk of countries according to reported or estimated real situation, respectively.    
 
(1) ρ3 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is 
obtained by multiplying attack rate of last 14 days per 105 inhabitants (i.e. density of cases) by ρ7 (a value related with 
effective reproduction number and that, therefore, determines the dynamics for subsequent days). EPGEST is obtained 
by multiplying estimated real attack rate of last 14 days per 105 inhabitants by ρ7. 
 
Highlights for countries with highest number of reported cases 
 Spain is revising historical series of other regions with minor variations, including a one-day peak of 
2,700 cases in Catalunya (so, ρ7 not reliable). 
 Spain, Italy, Germany and France are clearly below the level of 1,000 daily cases. UK could situate 
below 3,000 the next days. 





Time indicators by country 
This table summarizes a few time indicators for each country: time since 50 cases were reported, time 
interval between an attack rate of 1/105 inhabitants and an attack rate of 10/105 inhabitants, and time 





Analysis: Assessment on the relevance of testing and mobility in the next stage of 
the epidemic. 
The slow process of reopening the economy, with the consequent increase in mobility and contacts, requires 
multiple measures to check that it is done carefully so that new outbreaks are small and can be controlled. 
In this sense, the ability to contact and trace becomes crucial. The ability to test and trace depends on three 
interacting factors: 
1) Setting up the laboratory structure which allows the performance of a large number of tests at the 
local medical centers. In this sense, we have established the DTL of an area (Daily Testing Level) as 
the key number defined as the number of tests a region or country can do per day per 100.000 
people. We have explained in previous reports that countries showing DTL≈50-100 indicate that they 
have a reliable structure to do tests. 
2) The ability to find all people in close contact with a positive case and put them in quarantine 
requires a minimum structure of people making calls and requesting isolation. These people should 
be tested immediately upon the appearance of symptoms. It is thus important to have an index 
indicating the level of tracing requested. 
3) Mobility and interactions with people who are not familiar to the infected people transform the 
problem of contacting with close ties to a much more challenging process of tracking sustained 
contacts with strangers in public gatherings. These long interactions with people without kinship 
happen in classes/training, long commutes in trains/buses/planes, bars and restaurant interiors, 
socio-cultural gathering (theatre, cinema, sports…). 
In the present stage of the epidemics when mass gatherings are not allowed, we state that these three 
factors can be taken into account by two indexes, one relating with the ability to do tests compared with 
the number of cases and the other on mobility to obtain a surrogate for an upper bound on the number of 
contacts a possible positive case can interact with. 
We focus today on the ability to test the infectious population and its close contacts, and we will devote 
subsequent reports to mobility. Regarding the former, both the DTL and the number of estimated active 
cases becomes crucial. We defend that a proper picture of the challenges a particular country faces to do 
contact and trace of close relatives is given by the index DTL/A14,EST, where A14,EST is the number of estimated 
active cases per 105 inhabitants. This index defines the number of tests divided by the number of infected 
people per 105 inhabitants that can propagate the disease. It defines the tracing capability as a ratio, so we 
call it TCR (Tracing Capability Ratio). A low value makes contact tracing impossible while a large value makes 
it perfectly feasible. A large value allows for contact tracing at the local level as long as there is a minimum 
of staff who can call the kinship contacts of those tested positive. 
The number of estimated active cases can be obtained from the diagnostic rate (DR) of each country with a 
methodology that we confirmed in the report yesterday. Here we provide a table for key countries. While 
there are huge differences between states within the United States and regions within each country, this 




(1) This is not the last value, but the maximum number achieved.
We can divide the countries in three clear groups. First, those with TCF>1 are already doing test and tracing 
with no major difficulties. Clearly TCF>1 indicates that the system is ready. TCF<0.25 is an index too low, 
making test and tracing very difficult or impossible. The fact that this is aggregated data for countries means 
that some areas within countries can start the process but, in general, UK, USA or France are not ready to 
test and trace successfully. 
Finally, those with TCF>0.25 but TCF<1 are countries which can try the implementation of the test and trace 
scheme in those areas of the country less affected. Let us focus here on the meaning of TCF as a number and 
why TCF≈0.25-0.5 marks the effective threshold to start test and tracing.  Given that people spend roughly 4 
days without symptoms, it means that you have at least four days of testing available to cover new cases. 
Therefore, TCF at 1/4= 0.25 is a good rule of thumb number that fits those countries who are able to start 
the process 
With values of TCF around 0.5, a country/region is able to test all the new cases appearing every day and 
all the close contacts who may develop symptoms (50-60%) and still have some spare capacity to test and 
trace old cases. Countries with TCF around 0.25 can probably track new cases but it is difficult for them to 
process the backlog of 14 days of active cases.  
TCF at these values also indicate the presence of regions or areas where test and tracing can be done within 
each country. For example, in the case of Spain, using DTL=85 and a typical diagnosis rate of 8% we can 
compute the TFC for nine regions which 
represent the typical variability we find in 
Spain. 
It is clear from this table that Spain, and 
probably Italy too, can try to test and trace 
new cases in areas with low active cases but 
will have more serious problems in areas 
with higher incidence like Castilla y León, 
Madrid and Catalunya given the large 
backlog of cases. Similarly, areas like 
Asturias or Murcia are perfectly capable to 
test and trace all infected.  
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Long-term predictions 
Long-term predictions, evaluated with the whole historical series and without weighting last 3 points. Up-
left: Predictions of maximum incidences per country (total final expected attack rate per 105 inh.). Up-right: 
Predictions of maximum absolute number of cases per country (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date.  
 
Final expected K for UE+EFTA+UK. Evolution of 
predicted K with time, where convergence to best 
estimate is seen. Last prediction is numerically 









Italian regions  
 
 










* This report has been elaborated without consolidated dataseries from ISCiii, so the results are provisional (data 
published by Health Ministry). 
(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is 
obtained by multiplying attack rate of last 14 days per 105 inhabitants (i.e. density of cases) by ρ7 (a value related with 
effective reproduction number and that, therefore, determines the dynamics for subsequent days). EPGEST is obtained 
by multiplying estimated real attack rate of last 14 days per 105 inhabitants by ρ7. 
 





Legend: Countries’ reports details 
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 







































WARNING 1: Data from Catalunya and Spain are 
provisional, pending on the indication to locate 
2715 old cases. 
WARNING 2: These reports have been elaborated 
without consolidated dataseries from ISCiii, so 








(3) Analysis and prediction of COVID-19 




























































 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale  
 
(4) Analysis and prediction of COVID-19 























































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports1, from European Centre 
for Disease Prevention and Control (ECDC)2 and from Ministerio de Sanidad3. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 




https://github.com/datadista/datasets/tree/master/COVID%2019 , https://covid19.isciii.es/ 
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(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model4 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          
4 Madden LV. Quantification of disease progression. Protection Ecology 1980; 2: 159-176. 
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• Group A: prediction of expected cumulated cases for the following 3-5 days5; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors6 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
5 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
6 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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